FR2342741A1 - Compositions a action biologique comprenant une matrice biodegradable et au moins une substance biologiquement active - Google Patents

Compositions a action biologique comprenant une matrice biodegradable et au moins une substance biologiquement active

Info

Publication number
FR2342741A1
FR2342741A1 FR7706435A FR7706435A FR2342741A1 FR 2342741 A1 FR2342741 A1 FR 2342741A1 FR 7706435 A FR7706435 A FR 7706435A FR 7706435 A FR7706435 A FR 7706435A FR 2342741 A1 FR2342741 A1 FR 2342741A1
Authority
FR
France
Prior art keywords
biologically
active substance
biodegradable matrix
acting compositions
biologically active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7706435A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
COMMW SERUM LABO COMMISSI
Original Assignee
COMMW SERUM LABO COMMISSI
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by COMMW SERUM LABO COMMISSI filed Critical COMMW SERUM LABO COMMISSI
Publication of FR2342741A1 publication Critical patent/FR2342741A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6087—Polysaccharides; Lipopolysaccharides [LPS]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
FR7706435A 1976-03-04 1977-03-04 Compositions a action biologique comprenant une matrice biodegradable et au moins une substance biologiquement active Withdrawn FR2342741A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPC510876 1976-03-04

Publications (1)

Publication Number Publication Date
FR2342741A1 true FR2342741A1 (fr) 1977-09-30

Family

ID=3766563

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7706435A Withdrawn FR2342741A1 (fr) 1976-03-04 1977-03-04 Compositions a action biologique comprenant une matrice biodegradable et au moins une substance biologiquement active

Country Status (7)

Country Link
JP (1) JPS52125613A (fr)
AU (1) AU513400B2 (fr)
CA (1) CA1084413A (fr)
DE (1) DE2709488A1 (fr)
FR (1) FR2342741A1 (fr)
GB (1) GB1567503A (fr)
NZ (1) NZ183458A (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0140255A2 (fr) * 1983-10-14 1985-05-08 Sumitomo Pharmaceuticals Company, Limited Injections à libération prolongée
EP0246809A2 (fr) * 1986-05-19 1987-11-25 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions pharmaceutiques à libération retardée
US4774091A (en) * 1983-10-14 1988-09-27 Sumitomo Pharmaceuticals Company, Ltd. Long-term sustained-release preparation

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54126648U (fr) * 1978-02-24 1979-09-04
JPS54127551U (fr) * 1978-02-25 1979-09-05
CA1143289A (fr) * 1978-10-17 1983-03-22 Lee R. Beck Systeme de liberation de medicaments sous forme de microparticules
US5385738A (en) * 1983-10-14 1995-01-31 Sumitomo Pharmaceuticals Company, Ltd. Sustained-release injection
JPS6089418A (ja) * 1983-10-20 1985-05-20 Sumitomo Chem Co Ltd 徐放性制癌剤
DE3500268A1 (de) * 1985-01-05 1986-07-10 Hoechst Ag, 6230 Frankfurt Praeparate mit verzoegerter wirkung, verfahren zu deren herstellung sowie entsprechende mittel zur human- bzw. veterinaermedizinischen anwendung
US5902565A (en) * 1993-12-24 1999-05-11 Csl Limited Spray dried vaccine preparation comprising aluminium adsorbed immunogens
JPWO2008072379A1 (ja) * 2006-12-13 2010-03-25 富士フイルム株式会社 修飾された生体高分子の製造方法及び生体高分子の架橋方法
JP5047603B2 (ja) * 2006-12-15 2012-10-10 エア・ウォーター株式会社 ゼラチン成形物およびその製造方法

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0140255A2 (fr) * 1983-10-14 1985-05-08 Sumitomo Pharmaceuticals Company, Limited Injections à libération prolongée
EP0140255A3 (en) * 1983-10-14 1985-10-30 Sumitomo Chemical Company, Limited Sustained-release injections
US4774091A (en) * 1983-10-14 1988-09-27 Sumitomo Pharmaceuticals Company, Ltd. Long-term sustained-release preparation
US5021241A (en) * 1983-10-14 1991-06-04 Sumitomo Pharmaceuticals Company, Limited Long-term sustained-release preparation
EP0246809A2 (fr) * 1986-05-19 1987-11-25 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions pharmaceutiques à libération retardée
EP0246809A3 (en) * 1986-05-19 1988-01-13 Yissum Research And Development Company Of The Hebrew University Of Jerusalem Sustained-release pharmaceutical compositions

Also Published As

Publication number Publication date
JPS52125613A (en) 1977-10-21
NZ183458A (en) 1979-10-25
CA1084413A (fr) 1980-08-26
AU2295877A (en) 1978-09-07
DE2709488A1 (de) 1977-10-27
AU513400B2 (en) 1980-11-27
GB1567503A (en) 1980-05-14

Similar Documents

Publication Publication Date Title
BE852206A (fr) Applicateur d'etiquettes agencees en matrice
IT1143638B (it) Antiparassitario contenente derivati 2-propinilamminici,in particolare con azione insetticida e ovicida
ES2018451A4 (es) Material microencapsulado agricolamente activo
AT355871B (de) Insektizide zusammensetzung
FR2342741A1 (fr) Compositions a action biologique comprenant une matrice biodegradable et au moins une substance biologiquement active
IT1076627B (it) Matrice di memoria
IL51616A (en) N-(5-tetrazolyl)-4-oxo-4h-pyrimido (2,1-b) benzothiazole-3-carboxamides and pharmaceutical compositions containing them
SE8207520D0 (sv) Porosa material innehallande en biologiskt aktiv substans
AU2611177A (en) Biologically active compositions
IT1090777B (it) Copolimeri biologicamente attivi utili come antivegetativi ed anti incrostanti
IT7822019A0 (it) Composizione farmaceutica adattivita' antibroncospastica e antitosse.
BR7702313A (pt) Ester de piperidila,composicao de materia e sua aplicacao
BR7601445A (pt) Composicao inseticida e acaricida
IT1109230B (it) Composizione insetticida ed acaricida
SE7712328L (sv) Biologiskt aktiva kompositioner
AR218262A1 (es) Una composicion insecticida y acaricida sinergizada
DK135807B (da) Insecticidt og acaricidt virksomme n-sulfenylerede 2,3-dihydrobenzofuranyl-7-n-methylcarbamater
BE861368A (fr) Nouvelle composition insecticide
SE7711055L (sv) Biocidiskt aktiva kompositioner
FR2302686A1 (fr) Composition acaricide a base d'une phosphine et son application
BE855456A (fr) Composition et son utilisation dans des systemes a ph eleves
NL7801137A (nl) Biologisch actieve stof.
IT1141261B (it) Composizione insetticida e acaricida
PL205322A1 (pl) Srodek biologicznie czynny
IT1079487B (it) Perfezionamento nelle composizioni insetticide selettive

Legal Events

Date Code Title Description
ST Notification of lapse